Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Hydroxyapatite (MCHC) vs Iron: Iron has the stronger overall evidence (9 vs 4.5/10); they work on different things and are often used together, not either/or. Take the 2-minute quiz for a pick tailored to your goals.
Iron wins 2 of 3 categories.
Verdict
Too few graded studies
Top outcomes
Verdict
Helped
6 of 10 studies with measurable effects showed benefit.
Top outcomes
No matched minimum effective dose established here
Use the labelled elemental calcium amount when counting calcium intake, rather than the weight of the whole compound. Include calcium from food and other supplements.
Split doses with meals, Morning and evening
Ossein-hydroxyapatite compound tablets
18-40mg elemental iron for deficiency (varies by severity) (a typical label dose, not the dose used in the cited trials, which used 60 to 120 mg a day)
On empty stomach if tolerated, Away from tea, coffee, dairy
Ferrous bisglycinate (gentle, well-absorbed) or iron protein succinylate
and 7 more not shown
and 6 more not shown
In single-meal studies of other calcium sources, 300-600 mg calcium reduced iron absorption by 50-60%. Long-term studies of raised calcium intake show no change in iron status, so this is an acute absorption effect that matters most for people treating iron deficiency. The precaution is provisional, extrapolated from those other calcium sources.
While treating iron deficiency, take iron at a different time of day from hydroxyapatite and other calcium products. A gap of about 2 hours is a practical schedule, not an interval tested in studies.
12-36 months
N/A
Hours to 3 months
5-6 months
2-4 weeks
4-8 weeks
4-12 weeks
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.
Menopause (2009) · Meta-Analysis
Meta-analysis of randomised controlled trials comparing ossein-hydroxyapatite complex (OHC) with calcium carbonate, not with placebo. Of 18 controlled trials identified, 6 were pooled in a random-effects model, and the abstract does not give the total number of participants.
Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.
Osteoporos Int (1995) · RCT · n=40
Randomised, double-masked trial in 40 women with postmenopausal osteoporosis, each given 1,400 mg calcium a day as either OHC or calcium carbonate for 20 months.
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Clin Drug Investig (2011) · RCT · n=120
Randomised, open-label trial in 120 women over 65 with osteoporosis (55 OHC, 65 calcium carbonate), of whom 54 completed 3 years. OHC gave 712 mg elemental calcium a day and calcium carbonate 1,000 mg, and both groups also took calcifediol.
Daily oral iron supplementation during pregnancy
The Cochrane database of systematic reviews (2024) · Meta-Analysis · n=48971
There is probably little to no difference in maternal death (2 versus 4 events, RR 0.57, 95% CI 0.12 to 2.69; 3 trials, 14,060 women; moderate-certainty evidence).
The Prevalence of Anemia among Pregnant Women in China: A Systematic Review and Meta-Analysis
Nutrients (2024) · Meta-Analysis · n=1376204
The results showed that the prevalence of anemia, ID, and IDA among pregnant women in China were 30.7% (95% CI: 26.6%, 34.7%), 45.6% (95% CI: 37.0%, 54.2%), and 17.3% (95% CI: 13.9%, 20.7%), respectively.
Treatment for women with postpartum iron deficiency anaemia
The Cochrane database of systematic reviews (2024) · Meta-Analysis · n=4558
Intravenous iron versus oral iron supplementation The evidence is very uncertain about the effect of intravenous iron on mortality (risk ratio (RR) 2.95, 95% confidence interval (CI) 0.12 to 71.96; P = 0.51; I² = not applicable; 3 RCTs; 1 event; 572 women; very low-certainty evidence).
Iron has a higher evidence score (9/10 vs 4.5/10) and wins in 2 of 3 categories.
In single-meal studies of other calcium sources, 300-600 mg calcium reduced iron absorption by 50-60%. Long-term studies of raised calcium intake show no change in iron status, so this is an acute absorption effect that matters most for people treating iron deficiency. The precaution is provisional, extrapolated from those other calcium sources. While treating iron deficiency, take iron at a different time of day from hydroxyapatite and other calcium products. A gap of about 2 hours is a practical schedule, not an interval tested in studies. Consult a healthcare provider for personalized advice.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
Selenium helps; iodine can WORSEN Hashimoto’s. The honest take on "thyroid support".
What’s safe while nursing, the truth about milk-supply herbs, and what to avoid (it passes into milk).
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.